Download Regadenoson Report

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

History of invasive and interventional cardiology wikipedia , lookup

Electrocardiography wikipedia , lookup

Cardiac surgery wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Management of acute coronary syndrome wikipedia , lookup

Coronary artery disease wikipedia , lookup

Dextro-Transposition of the great arteries wikipedia , lookup

Transcript
Dr. Who Cardiology
123 Anystreet Lane
Ellicott City, MD 21045
Phone: 410-808-1000
Fax: 410-808-1010
Myocardial Perfusion Imaging
Patient Name: Doe, Jack
Sex: Male
ID Number: 123000
Referring Physician: Dr. Who
Date of Birth: 05/07/1945
Date of Exam: 11/20/2015
Height: 64 inches
Weight: 145 lbs
Protocol: 1 Day Regadenoson rest/stress Tc99m Myoview
History: This is a 70 year old man with a history of coronary artery disease. He had coronary artery
bypass surgery in 1996.
Clinical Indications: Assessment of chest pain
Procedure: The patient was given 0.4 mg Regadenoson intravenously over 15 seconds. The patient
developed shortness of breath during the procedure. Heart rate was 75 bpm at baseline increasing to
113 bpm after Regadenoson injection. The blood pressure response was hypertensive. The baseline
blood pressure was 160/88 mmHg and 192/68 mmHg after the Regadenoson injection. The resting EKG
was normal and the peak EKG demonstrated no ischemic changes. There were no significant
dysrhythmias noted during Regadenoson injection or recovery.
At rest 9.5 mCi Tc99m Myoview was injected intravenously followed by SPECT imaging. At 30 seconds
after the Regadenoson injection 30.0 mCi Tc99m Myoview was injected intravenously. SPECT imaging
was performed with electrocardiographic gating.
Findings: The overall quality of the study is good. Left ventricular cavity size is normal. LVH is absent.
TID ratio is normal. There is no significant motion artifact.
The SPECT images demonstrate a small to medium sized area of mild to moderate reduced perfusion in
the anterior and anteroapical region. When comparing rest and stress images this defect is completely
reversible and consistent with mid- LAD territory ischemia. The post stress gated study demonstrates a
normal post stress ejection fraction of 65% with normal wall motion and normal wall thickening.
Impression:
1. This is an abnormal myocardial perfusion study with evidence for LAD territory ischemia, normal
wall motion, and a normal post stress ejection fraction.
2. Compared to the prior study from October 18, 2011, the current study reveals new LAD territory
ischemia
3. The above results were discussed with the patient. He will be scheduled for a cardiac
catheterization.
Electronically signed by Maria Costello, MD 11/20/2015 10:51
MPI Pharmacologic Stress Abnormal Report (SAMPLE)
Note: This is a SAMPLE only. Reports submitted with the application MUST be customized to reflect current practices of the facility.